Shrink Nanotechnologies' MetalFluor Technology Featured in Applied Physics Letters

Shrink Nanotechnologies, Inc. ("Shrink") (OTC Bulletin Board: INKN), an innovative nanotechnology company developing products and licensing opportunities in the solar energy industry, medical diagnostics and sensors and biotechnology research and development tools businesses, announced today that Shrink's MetalFluor™ technology was studied, reported on and made the front cover of the November issue of Applied Physics Letters.

The Company's technology and the work being performed by Dr. Michelle Khine, our scientific founder, continues to gain high praise from leading academic journals.  The studies relate to potential commercial applications of this technology.  Of note, the article states, "Because we have a range of nanostructure and nanogap sizes, we can ensure that we can achieve huge fluorescent enhancements on our substrate.  These advantages show great potential for low-cost biomedical sensing at single molecular levels at physiological concentrations."  The Company believes that this article is further evidence that certain medical diagnostics tests, a multi-billion dollar annual industry in the United States alone, can provide physicians, patients and other medical professionals with better results using lower quantities of specimens using MetalFluor™ technologies.

Shrink intends to soon commercially offer the tools that Dr. Khine has used to achieve the results features in the most recent Applied Physics Letters.  The Company intends to provide an additional update next week regarding our initial NanoShrink product and the related NanoShrink line, according to Mark L. Baum, Shrink's CEO.


Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback